Immuno-Engineering the Future of Wellness—Sawsan Youssef—Chief Scientific Officer at Distributed Bio
Finding Genius Podcast
Richard Jacobs
4.4 • 1K Ratings
🗓️ 7 July 2020
⏱️ 38 minutes
🧾️ Download transcript
Summary
Chief Scientific Officer at Distributed Bio, Sawsan Youssef, joins the show to discuss her work at this unique company, and why it might hold promise for treating the COVID-19 virus and other medical conditions.
In this episode, you will learn:
- What an antibody is, and how antibody therapeutics are developed
- How antibody therapy might prevent the COVID-19 virus from binding to host cells, thereby preventing illness
- How Distributed Bio identifies which antibodies will provide the most optimal binding properties at optimal binding sites for a given virus or disease
Distributed Bio is a small, self-funded biotechnology company that's creating new technologies for therapeutics in a variety of medical fields by using immunology as the platform. There are two type of therapeutics in their current portfolio: one that relies on antibody generation, and one that is vaccine-based. In response to the COVID-19 pandemic, Distributed Bio is developing a therapeutic which is based on the use of antibodies.
Youssef explains the science and biology behind how antibody therapy works and why the use of antibodies to combat viruses is not only effective, but less likely to cause dangerous side effects. Generally speaking, antibodies are a good type of therapeutic because they are well-tolerated by the body and target precisely what you're aiming for. In contrast, the use of other small molecules in therapeutics might target what you're aiming for, but they may also target multiple other pathways in the body along the way, leading to adverse effects.
Youssef discusses a number of other important topics, including how this technology could treat autoimmune diseases like lupus, the role of antibody therapeutics in the field of oncology, in what ways some viruses are able to render binding antibodies ineffective, and the timeframe on the COVID-19 therapeutic that's in the works.
Press play for all the details, and learn more about these technologies at https://www.distributedbio.com/.
Available on Apple Podcasts: apple.co/2Os0myK
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Forget frequently asked questions. |
| 0:02.0 | Common sense, common knowledge, or Google. |
| 0:05.0 | How about advice from a real genius? |
| 0:07.0 | 95% of people in any profession are good enough to be qualified and licensed. |
| 0:11.0 | 5% go above and beyond. They become very good at what they do, but only 0.1% are real Jesus. |
| 0:18.0 | Richard Jacobs has made it his life's mission to find them for you. He hunts down and interviews geniuses in every field, sleep science, |
| 0:25.7 | cancer, stem cells, ketogenic diets, and more. Here come the geniuses. This is the Finding Genius |
| 0:32.1 | podcast that Richard Jacobs. This is the Finding Genius Podcast. |
| 0:33.0 | That is Richard Jacobs. |
| 0:35.0 | Hello, this is Richard Jacobs with the Finding Genius Podcast. |
| 0:41.0 | I have Saucin-Yousf. She's the chief scientific officer at Distributed |
| 0:46.4 | Bio and we're going to talk about the work that she does there. So, |
| 0:49.4 | Sosen, thanks for coming. How you doing today? Thanks for having me. I'm doing great. |
| 0:54.0 | Oh good, good. So tell me about first about |
| 0:57.6 | Distributed Bio. What is the company about? |
| 1:00.0 | So Distributed Bio is a very unique small biotech company that is based on |
| 1:09.6 | immune engineering, basically engineering new technologies |
| 1:16.0 | for developing new therapeutics in the field, |
| 1:20.9 | in any medicinal field using immunology as the platform and generating different platforms to develop antibody therapeutics for from inflammation to cancer to |
| 1:40.2 | vaccine to viral vaccines and the uniqueness about distributed bio is we are self-funded so we don't rely on |
| 1:50.8 | venture capitalists we support ourselves so part of using these platforms as a way of |
| 1:59.3 | generating as a CRO services to generate therapeutics, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Richard Jacobs, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Richard Jacobs and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.